Big4Bio Podcast

Surviving and Thriving in the Long Biotech Winter Kevin Sarney

"The IPO market remains unwelcoming to biotechs and venture investors are reticent to back younger companies. In the absence of reliable funding sources, many biotechs are trying to advance their most promising programs while keeping their operations lean until they can get to a fundable milestone. Big4Bio podcast talked to CRCFO's Kevin Sarney, about the current uncertainty biotechs face, the need for capital efficiency, and how companies can best prepare for future opportunities."

---

How can we support you in achieving your firm's financial sustainability and growth?

If you would like to discuss how our biotech CFO services can assist your company please get in touch with us at (781) 431-0420 x1 or email us.